Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats

European Journal of Pharmacology

Volumn 353, Issue 2-3, 1998, Pages 227-237

  Lahlou, Saad ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cardiovascular effect; Dopamine D2 receptor, spinal; Intrathecal domperidone; Normotensive rat; Quinpirole; Spinal mediation, partial

Indexed keywords

DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; HALOPERIDOL; METOCLOPRAMIDE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0032563171     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00397-5     Document Type: Article

References (49)

1. 2) receptors in the anesthetized dog. Eur. J. Pharmacol. 87, 165-166.
2. Arneric, S.P., Chow, S.A., Long, J.P., Fischer, L.J., 1984. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas. J. Pharmacol. Exp. Ther. 288, 551-559.
3. Cavero, I., Massingham, R., Lefevre-Borg, F., 1982a. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part II. Sites and mechanisms of action of dopamine receptor agonists. Life Sci. 31, 1059-1069.
4. Cavero, I., Massingham, R., Lefevre-Borg, F., 1982b. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part I. Subclassification and functional description. Life Sci. 31, 939-948.
5. Cavero, I., Thiry, C., Pratz, J., Lawson, K., 1987. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Clin. Exp. Hypertens. A 9, 931-952.
6. Champion, M.C., 1988. Domperidone. Gen. Pharmacol. 19, 499-505.
7. 2-agonist LY171555. J. Cardiovasc. Pharmacol. 6, 1245-1248.
8. Demenge, P., Mouchet, P., Guérin, B., Feuerstein, C., 1981. Identification and distribution of neuroleptic binding sites in the rat spinal cord. J. Neurochem. 37, 53-59.
9. 2 dopamine receptors. Neuroscience 19, 125-137.
10. Feuerstein, C., Mouchet, P., Manier, M., Moussaoui, S., Mons, N., Geffard, M., Dielt, M., Arluison, M., Petitjean, P., Demenge, P., 1988. Dopaminergic relationships in the rat spinal cord. In: Sandler, M., Dahlstrom, A., Belmaker, R.H. (Eds.), Progress in Catecholamine Research, Part B: Central aspects. Alan R. Liss, New York, NY, pp. 529-536.
11. Fleetwood-Walker, S.M., Hope, P.J., Mitchell, R., 1988. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J. Physiol. (London) 399, 335-348.
12. Gradin, K., 1990. Interactions between substance P and serotonergic mechanisms at preganglionic sympathetic nerves in thoracic spinal cord. Acta Physiol. Scand. 138, 101-102.
13. Hahn, R.A., MacDonald, B.R., 1984. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-Propyldopamine and LY171555. J. Pharmacol. Exp. Ther. 229, 132-138.
14. Hahn, R.A., MacDonald, B.R., Martin, M.A., 1983. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist. J. Pharmacol. Exp. Ther. 224, 206-214.
15. Hökfelt, T., Phillipson, O., Goldstein, M., 1979. Evidence for a dopaminergic pathway in the rat descending from the All cell group to the spinal cord. Acta Physiol. Scand. 107, 393-395.
16. Jensen, T.S., Smith, D.F., 1982. Dopaminergic effects on tail-flick response in spinal rats. Eur. J. Pharmacol. 79, 129-133.
17. Jensen, T.S., Smith, D.F., 1983. Role of 5-HT and NA in spinal dopaminergic analgesia. Eur. J. Pharmacol. 86, 65-70.
18. Kohli, J.D., Glock, D., Goldberg, L.I., 1983. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur. J. Pharmacol. 89, 137-141.
19. Kubo, T., Nagura, J., Misu, Y., 1987. Pharmacological characterization of spinal alpha adrenoceptors related to blood pressure control in rats. J. Pharmacol. Exp. Ther. 240, 298-302.
20. Kurz, K., Main, B., Moore, R., Smith, T., 1986. Differential effects of the selective dopamine (DA) agonist, quinpirole, on blood pressure in conscious normotensive and hypertensive rats. Fed. Proc. 45, 1071, (Abstr.).
21. Laduron, P.M., Leysen, J.E., 1979. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem. Pharmacol. 28, 2161-2165.
22. Lahlou, S., Demenge, P., 1991. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats. J. Cardiovasc. Pharmacol. 18, 317-325.
23. Lahlou, S., Demenge, P., 1992. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors. J. Cardiovasc. Pharmacol. 19, 723-731.
24. Lahlou, S., Demenge, P., 1993. Cardiovascular responses to intrathecal dopamine receptor agonists after spinal transection in conscious rats. Cardiovasc. Res. 27, 222-230.
25. Lahlou, S., Petitjean, P., Pellissier, G., Mouchet, P., Feuerstein, C., Demenge, P., 1990. Rostrocaudal localization of cardiovascular responses induced by intrathecal administration of apomorphine in conscious, freely moving rats. J. Cardiovasc. Pharmacol. 16, 331-337.
26. Langer, S.Z., 1981. Comparative analysis of presynaptic inhibition of noradrenaline release by alpha-2 and dopamine receptors. Acta Pharmacol. Toxicol. 49, 20-21.
27. 2 dopamine receptor agonist quinpirole in rats. Fundam. Clin. Pharmacol. 1, 179-200.
28. 8-vasopressin produces different cardiovascular responses in conscious and anesthetized rats. Am. J. Physiol. 256, R193-200.
29. Nagahama, S., Chen, Y.F., Oparil, S., 1984. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 228, 370-375.
30. 2 receptor agonist, in the conscious rat. J. Pharmacol. Exp. Ther. 236, 735-742.
31. 2 receptor agonist, in the anesthetized rat. J. Pharmacol. Exp. Ther. 239, 426-432.
32. 2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats. J. Pharmacol. Exp. Ther. 242, 143-151.
33. 2 receptor agonists and antagonists. J. Cardiovasc. Pharmacol. 18, 548-555.
34. Peringer, E., Jenner, P., Donaldson, I.M., Marsden, C.D., 1976. Metoclopramide and dopamine receptor blockade. Neuropharmacology 15, 463-469.
35. Petitjean, P., Mouchet, P., Pellissier, G., Manier, M., Feuerstein, C., Demenge, P., 1984. Cardiovascular effects in the rat of intrathecal injections of apomorphine at the thoracic spinal cord level. Eur. J. Pharmacol. 105, 355-359.
36. Ruffolo, Jr., R.R. Shaar, C.J., 1983. Relative potency of LY141865 at dopamine DA2 and histamine H2 receptors. Eur. J. Pharmacol. 92, 295-296.
37. 3H]quinpirole. Eur. J. Pharmacol. 203, 105-109.
38. Sengupta, S., Lokhandwala, M.F., 1985. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anesthetized rats. J. Auton. Pharmacol. 5, 289-294.
39. Skagerberg, G., Björklund, A., Lindvall, O., Schmidt, R.H., 1982. Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res. Bull. 9, 237-244.
40. Stoof, J.C., Kebabian, J.W., 1984. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35, 2281-2296.
41. Sved, A.F., Fernstrom, J.D., 1980. Evidence for a peripheral dopaminergic mechanism in the antihypertensive action of lergotrile. Life Sci. 27, 349-354.
42. Takano, Y., Martin, J.E., Leeman, S.E., Loewy, A.D., 1984. Substance P immunoreactivity released from rat spinal cord after kainic acid excitation of the ventral medulla oblongata: a correlation with increases in blood pressure. Brain Res. 291, 168-172.
43. Tsuruta, K., Frey, E.A., Grewe, C.W., Cote, T.E., Eskay, R.L., Kebabian, J.W., 1981. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature 292, 463-465.
44. Van den Buuse, M., 1992. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 262, 303-311.
45. Van den Buuse, M., 1997. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and α-methyldopa in conscious rats. Eur. J. Pharmacol. 322, 191-199.
46. Van den Buuse, M., Morton, S.J., Cornish, J.L., Head, G.A., 1996. Prolonged central effects of quinpirole on cardiovascular regulation. J. Pharmacol. Exp. Ther. 227, 473-483.
47. Van Dijken, H., Dijk, J., Voom, P., Holstege, J.C., 1996. Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization. Eur. J. Neurosci. 8, 621-628.
48. Weil-Fugazza, J., Godefroy, F., 1991. Further evidence for the involvement of the diencephalo-dopaminergic system in pain modulation: a neurochemical study on the effect of morphine in the arthritic rat. Int. J. Tissue React. 6, 305-310.
49. Willems, J.L., Buylaert, W.A., Lefevre, R.A., Bogaert, M.G., 1985. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol. Rev. 37, 165-216.